Dmard

PHILADELPHIA — Patients with rheumatoid arthritis frequently switched between JAK inhibitors in Australia, according to a presentation at ACR Convergence 2022.

What does the PAPA spectrum disorder teach us about SAPHO? Is SAPHO an autoinflammatory condition or part of the SpA spectrum? Why have antibiotics been used to treat this condition? Find out in this episode!

Although data supporting cannabis use in patients with rheumatic diseases “continue to grow,” most of the recent literature have been reviews rather than primary research, according to a review published in Current Rheumatology Reports.

Molecular signature response classifier-assisted rheumatoid arthritis treatment selection may improve real-world results in patients with rheumatoid arthritis, according to data published in Expert Opinion on Biological Therapy.

Despite guidelines recommending early and aggressive therapy in rheumatoid arthritis, disease-modifying antirheumatic drug adoption for older patients remains low, according to data published in ACR Open Rheumatology.

Nurse-led education for patients with rheumatoid arthritis or spondyloarthritis, who are beginning biologic disease-modifying antirheumatic drugs, is effective at changing behaviors to prevent adverse events, according to data.

Tofacitinib for psoriatic arthritis is efficacious in most patient-reported and clinical endpoints over time, and shows shorter initial and meaningful response times versus switching from placebo to the drug at month 3, noted researchers.

The American College of Rheumatology has released two updated guideline papers for the treatment and management of juvenile idiopathic arthritis, according to a press release.

A machine learning model combining pharmacogenomic biomarkers with baseline DAS28 joint count predicted methotrexate response in early rheumatoid arthritis, according to data published in Arthritis Care & Research.

DMARD interruptions in patients with autoimmune rheumatic diseases increased more than 80% between December 2020 and May 2021, leading to higher rates of self-reported flares, according to data published in Arthritis Care & Research.